These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 26203087)

  • 1. Effect of vaccinations on seizure risk and disease course in Dravet syndrome.
    Verbeek NE; van der Maas NA; Sonsma AC; Ippel E; Vermeer-de Bondt PE; Hagebeuk E; Jansen FE; Geesink HH; Braun KP; de Louw A; Augustijn PB; Neuteboom RF; Schieving JH; Stroink H; Vermeulen RJ; Nicolai J; Brouwer OF; van Kempen M; de Kovel CG; Kemmeren JM; Koeleman BP; Knoers NV; Lindhout D; Gunning WB; Brilstra EH
    Neurology; 2015 Aug; 85(7):596-603. PubMed ID: 26203087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study.
    McIntosh AM; McMahon J; Dibbens LM; Iona X; Mulley JC; Scheffer IE; Berkovic SF
    Lancet Neurol; 2010 Jun; 9(6):592-8. PubMed ID: 20447868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine.
    Barlow WE; Davis RL; Glasser JW; Rhodes PH; Thompson RS; Mullooly JP; Black SB; Shinefield HR; Ward JI; Marcy SM; DeStefano F; Chen RT; Immanuel V; Pearson JA; Vadheim CM; Rebolledo V; Christakis D; Benson PJ; Lewis N;
    N Engl J Med; 2001 Aug; 345(9):656-61. PubMed ID: 11547719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination and occurrence of seizures in SCN1A mutation-positive patients: a multicenter Italian study.
    Zamponi N; Passamonti C; Petrelli C; Veggiotti P; Baldassari C; Verrotti A; Capovilla G; Viri M; Coppola G; Vignoli A
    Pediatr Neurol; 2014 Mar; 50(3):228-32. PubMed ID: 24405698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective study of the relation between vaccination and occurrence of seizures in Dravet syndrome.
    Tro-Baumann B; von Spiczak S; Lotte J; Bast T; Haberlandt E; Sassen R; Freund A; Leiz S; Stephani U; Boor R; Holthausen H; Helbig I; Kluger G
    Epilepsia; 2011 Jan; 52(1):175-8. PubMed ID: 21219303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study.
    Ray P; Hayward J; Michelson D; Lewis E; Schwalbe J; Black S; Shinefield H; Marcy M; Huff K; Ward J; Mullooly J; Chen R; Davis R;
    Pediatr Infect Dis J; 2006 Sep; 25(9):768-73. PubMed ID: 16940831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alleged cases of vaccine encephalopathy rediagnosed years later as Dravet syndrome.
    Reyes IS; Hsieh DT; Laux LC; Wilfong AA
    Pediatrics; 2011 Sep; 128(3):e699-702. PubMed ID: 21844054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
    Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
    Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early vaccinations are not risk factors for celiac disease.
    Myléus A; Stenlund H; Hernell O; Gothefors L; Hammarström ML; Persson LÅ; Ivarsson A
    Pediatrics; 2012 Jul; 130(1):e63-70. PubMed ID: 22732174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT.
    Le Saux N; Barrowman NJ; Moore DL; Whiting S; Scheifele D; Halperin S;
    Pediatrics; 2003 Nov; 112(5):e348. PubMed ID: 14595075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the Australian Childhood Immunisation Register for vaccine safety data linkage.
    Gold M; Dugdale S; Woodman RJ; McCaul KA
    Vaccine; 2010 Jun; 28(26):4308-11. PubMed ID: 20430123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Characteristics of Vaccination Triggered Seizures in Dravet Syndrome in Hong Kong: A Retrospective Study.
    Wong PT; Wong VC
    Pediatr Neurol; 2016 May; 58():41-7. PubMed ID: 26995069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic antipyretics for prevention of febrile seizures following vaccination.
    Monfries N; Goldman RD
    Can Fam Physician; 2017 Feb; 63(2):128-130. PubMed ID: 28209678
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of contraindicated medication use on cognitive outcome in Dravet syndrome and age at first afebrile seizure as a clinical predictor in SCN1A-related seizure phenotypes.
    de Lange IM; Gunning B; Sonsma ACM; van Gemert L; van Kempen M; Verbeek NE; Nicolai J; Knoers NVAM; Koeleman BPC; Brilstra EH
    Epilepsia; 2018 Jun; 59(6):1154-1165. PubMed ID: 29750338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis B vaccines by children?
    Bardenheier B; Yusuf H; Schwartz B; Gust D; Barker L; Rodewald L
    Arch Pediatr Adolesc Med; 2004 Jun; 158(6):569-75. PubMed ID: 15184221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis.
    Vestergaard M; Hviid A; Madsen KM; Wohlfahrt J; Thorsen P; Schendel D; Melbye M; Olsen J
    JAMA; 2004 Jul; 292(3):351-7. PubMed ID: 15265850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timely versus delayed early childhood vaccination and seizures.
    Hambidge SJ; Newcomer SR; Narwaney KJ; Glanz JM; Daley MF; Xu S; Shoup JA; Rowhani-Rahbar A; Klein NP; Lee GM; Nelson JC; Lugg M; Naleway AL; Nordin JD; Weintraub E; DeStefano F
    Pediatrics; 2014 Jun; 133(6):e1492-9. PubMed ID: 24843064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP-IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children.
    Klein NP; Weston WM; Kuriyakose S; Kolhe D; Howe B; Friedland LR; Van Der Meeren O
    Vaccine; 2012 Jan; 30(3):668-74. PubMed ID: 22064267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.